for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later

WASHINGTON, Sept 21 (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.

Asked which drugmaker could be approved, Trump told Fox News in an interview: “Pfizer’s doing really well,” adding “Johnson & Johnson ... they’ll probably be a little later.” He also cited efforts by Moderna Inc and AstraZeneca Plc. (Reporting by Susan Heavey)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up